Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Kowalski

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Leukemia & Lymphoma|September 5, 2022
T cell redirecting bispecific antibodies for multiple myeloma: emerging therapeutic strategies in a changing treatment landscapeDickran Kazandjian, Andrew Kowalski, Ola Landgren
Cureus|October 5, 2020
24 Hours: A Case of Multiorgan Failure Associated With COVID-19Diana Espinoza, Raul Rodriguez, Andrew Kowalski
Ochsner Journal|September 25, 2014
Diabetic nephropathy for the primary care provider: new understandings on early detection and treatmentAndrew Kowalski, Armand Krikorian, Edgar V Lerma
Langmuir : the ACS Journal of Surfaces and Colloids|August 25, 2015
Oleophobicity of Biomimetic Micropatterned Surface and Its Effect on the Adhesion of Frozen OilZihe Pan, Wei Zhang, Andrew Kowalski, et al.
Clinical Nephrology|August 27, 2015
Renal LECT2 amyloidosis: a newly described disorder gaining greater recognitionAndrew Kowalski, Julio Cabrera, Samih Nasr, et al.
Leukemia & Lymphoma|July 27, 2021
Real-world assessment of isocitrate dehydrogenase inhibitor-associated differentiation syndromeOxana Megherea, Carmen Janes, Andrew Kowalski, et al.
Expert Review of Hematology|January 18, 2021
Venetoclax for the treatment of elderly or chemotherapy-ineligible patients with acute myeloid leukemia: a step in the right direction or a game changer?Sonal Agarwal, Andrew Kowalski, Molly Schiffer, et al.
Blood Cancer Discovery|January 4, 2024
Emerging Strategies for the Prevention of Immune Toxicities Associated with T cell-Engaging Cancer TherapiesAndrew Kowalski, Jill Lykon, Benjamin Diamond, et al.
Leukemia & Lymphoma|December 16, 2020
High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasisJennifer Zhao, Jan Philipp Bewersdorf, Sara Jaszczur, et al.
Blood Advances|July 1, 2025
Tocilizumab Prophylaxis for Patients with Multiple Myeloma Treated with Bispecific AntibodiesAndrew Kowalski, Jillian Lykon, Benjamin T Diamond, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|September 5, 2022
T cell redirecting bispecific antibodies for multiple myeloma: emerging therapeutic strategies in a changing treatment landscapeDickran Kazandjian, Andrew Kowalski, Ola Landgren
Cureus|October 5, 2020
24 Hours: A Case of Multiorgan Failure Associated With COVID-19Diana Espinoza, Raul Rodriguez, Andrew Kowalski
Ochsner Journal|September 25, 2014
Diabetic nephropathy for the primary care provider: new understandings on early detection and treatmentAndrew Kowalski, Armand Krikorian, Edgar V Lerma
Langmuir : the ACS Journal of Surfaces and Colloids|August 25, 2015
Oleophobicity of Biomimetic Micropatterned Surface and Its Effect on the Adhesion of Frozen OilZihe Pan, Wei Zhang, Andrew Kowalski, et al.
Clinical Nephrology|August 27, 2015
Renal LECT2 amyloidosis: a newly described disorder gaining greater recognitionAndrew Kowalski, Julio Cabrera, Samih Nasr, et al.
Leukemia & Lymphoma|July 27, 2021
Real-world assessment of isocitrate dehydrogenase inhibitor-associated differentiation syndromeOxana Megherea, Carmen Janes, Andrew Kowalski, et al.
Expert Review of Hematology|January 18, 2021
Venetoclax for the treatment of elderly or chemotherapy-ineligible patients with acute myeloid leukemia: a step in the right direction or a game changer?Sonal Agarwal, Andrew Kowalski, Molly Schiffer, et al.
Blood Cancer Discovery|January 4, 2024
Emerging Strategies for the Prevention of Immune Toxicities Associated with T cell-Engaging Cancer TherapiesAndrew Kowalski, Jill Lykon, Benjamin Diamond, et al.
Leukemia & Lymphoma|December 16, 2020
High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasisJennifer Zhao, Jan Philipp Bewersdorf, Sara Jaszczur, et al.
Blood Advances|July 1, 2025
Tocilizumab Prophylaxis for Patients with Multiple Myeloma Treated with Bispecific AntibodiesAndrew Kowalski, Jillian Lykon, Benjamin T Diamond, et al.
Pageof 2